Kedan Chu

1.6k total citations
60 papers, 1.3k citations indexed

About

Kedan Chu is a scholar working on Molecular Biology, Complementary and alternative medicine and Neurology. According to data from OpenAlex, Kedan Chu has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Complementary and alternative medicine and 11 papers in Neurology. Recurrent topics in Kedan Chu's work include Traditional Chinese Medicine Analysis (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Medicinal Plants and Bioactive Compounds (7 papers). Kedan Chu is often cited by papers focused on Traditional Chinese Medicine Analysis (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Medicinal Plants and Bioactive Compounds (7 papers). Kedan Chu collaborates with scholars based in China, Macao and United States. Kedan Chu's co-authors include Lidian Chen, Wei Xu, Yuqin Zhang, Mingqing Huang, Wen Xu, Guizhu Hong, Yu Lin, Yicong Wei, Wenfang Lai and Xiaoqin Zhang and has published in prestigious journals such as International Journal of Molecular Sciences, Carbohydrate Polymers and Molecules.

In The Last Decade

Kedan Chu

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kedan Chu China 25 647 294 253 179 163 60 1.3k
Yajun Bai China 18 608 0.9× 166 0.6× 145 0.6× 97 0.5× 106 0.7× 84 1.3k
Zhifu Yang China 21 504 0.8× 232 0.8× 130 0.5× 120 0.7× 174 1.1× 56 1.2k
Jingping Ouyang China 22 733 1.1× 197 0.7× 74 0.3× 127 0.7× 199 1.2× 56 1.7k
Gilberto L. Pardo‐Andreu Cuba 24 433 0.7× 465 1.6× 162 0.6× 138 0.8× 262 1.6× 63 1.5k
Xiaolan Cheng China 28 929 1.4× 358 1.2× 82 0.3× 390 2.2× 229 1.4× 62 1.8k
Wenzhe Huang China 20 518 0.8× 243 0.8× 95 0.4× 245 1.4× 245 1.5× 102 1.2k
Guozhen Cui China 23 721 1.1× 217 0.7× 100 0.4× 149 0.8× 81 0.5× 85 1.5k
Shuping Zhang China 21 493 0.8× 144 0.5× 175 0.7× 76 0.4× 145 0.9× 47 996
Beibei Zhang China 18 471 0.7× 121 0.4× 123 0.5× 138 0.8× 115 0.7× 66 1.2k

Countries citing papers authored by Kedan Chu

Since Specialization
Citations

This map shows the geographic impact of Kedan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedan Chu more than expected).

Fields of papers citing papers by Kedan Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kedan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedan Chu. The network helps show where Kedan Chu may publish in the future.

Co-authorship network of co-authors of Kedan Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Kedan Chu. A scholar is included among the top collaborators of Kedan Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedan Chu. Kedan Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zelin, Wenfang Lai, Yingzheng Wang, et al.. (2020). Synthesis and identification of a novel derivative of salidroside as a selective, competitive inhibitor of monoamine oxidase B with enhanced neuroprotective properties. European Journal of Medicinal Chemistry. 209. 112935–112935. 24 indexed citations
2.
Wang, Xiaoying, Tonglei Li, Lifeng Han, et al.. (2019). Evaluation of intestinal permeation enhancement with carboxymethyl chitosan-rhein polymeric micelles for oral delivery of paclitaxel. International Journal of Pharmaceutics. 573. 118840–118840. 31 indexed citations
3.
Zhang, Yuqin, et al.. (2018). Compound GDC, an Isocoumarin Glycoside, Protects against LPS-Induced Inflammation and Potential Mechanisms In Vitro. Inflammation. 42(2). 506–515. 9 indexed citations
4.
5.
6.
Wang, Hongyun, et al.. (2017). Study on Species Homology and Quality Control of Two Kinds of Antrodia Cinnamomea. 24(8). 85–88. 1 indexed citations
7.
Wei, Yicong, Xiaoqin Zhang, Wenfang Lai, et al.. (2017). Salidroside Inhibits Inflammation Through PI3K/Akt/HIF Signaling After Focal Cerebral Ischemia in Rats. Inflammation. 40(4). 1297–1309. 84 indexed citations
8.
Lai, Wenfang, Xiaoqin Zhang, Yingzheng Wang, et al.. (2017). Inhibition of Complement Drives Increase in Early Growth Response Proteins and Neuroprotection Mediated by Salidroside After Cerebral Ischemia. Inflammation. 41(2). 449–463. 29 indexed citations
10.
Lai, Wenfang, Xiaoqin Zhang, Yicong Wei, et al.. (2015). Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window. Neurotoxicity Research. 28(2). 108–121. 30 indexed citations
11.
Zhang, Yuqin, et al.. (2015). Antioxidant and anti-excitotoxicity effect of Gualou Guizhi decoction on cerebral ischemia/reperfusion injury in rats. Experimental and Therapeutic Medicine. 9(6). 2121–2126. 12 indexed citations
12.
Huang, Mingqing, Peijian Wang, Wen Xu, et al.. (2015). Biological activities of salvianolic acid B fromSalvia miltiorrhizaon type 2 diabetes induced by high-fat diet and streptozotocin. Pharmaceutical Biology. 53(7). 1058–1065. 51 indexed citations
13.
Lin, Guoqing, et al.. (2014). Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Medical Oncology. 31(12). 327–327. 43 indexed citations
14.
Zhang, Yuqin, Li Huang, Kedan Chu, et al.. (2014). Neuroprotective effects of Gualou Guizhi decoction in vivo and in vitro. Journal of Ethnopharmacology. 158. 76–84. 20 indexed citations
15.
Chen, Xianwen, Mingqing Huang, Wei Xu, et al.. (2014). Effect of Gua Lou Gui Zhi decoction on focal cerebral ischemia-reperfusion injury through regulating the expression of excitatory amino acids and their receptors. Molecular Medicine Reports. 10(1). 248–254. 24 indexed citations
16.
Xu, Wei, Kedan Chu, Li Huang, et al.. (2013). Isolation and identification of compounds from Bauhinia championii (Benth.) Benth. International Journal of Phytomedicine. 5(1). 69–72. 1 indexed citations
17.
Chen, Keji, Zhenfeng Hong, Kedan Chu, et al.. (2012). Toxicity features of high glucose on endothelial cell cycle and protection by Dan Gua-Fang (丹瓜方) in ECV-304 in high glucose medium. Chinese Journal of Integrative Medicine. 19(8). 596–602. 6 indexed citations
18.
Yu, Lishuang, Hongzhi Ye, Lili Zheng, et al.. (2010). Determination of the epimerization rate constant of amygdalin by microemulsion electrokinetic chromatography. Electrophoresis. 32(2). 218–222. 16 indexed citations
19.
Chen, Keji, Kedan Chu, Wenlie Chen, et al.. (2008). Glucose endothelial cytotoxicity and protection by Dan Gua-Fang, a Chinese herb prescription in huVEC in hyperglycemia medium. Journal of Diabetes and its Complications. 23(5). 297–303. 9 indexed citations
20.
Chu, Kedan. (2005). Progress of Pharmacological Study on Breviscapine. Strait Pharmaceutical Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026